ALTIUS houses a life science team which boasts significant contentious, regulatory and transactional expertise. Its esteemed clientbase includes pharmaceutical, healthcare and biotech entities, who are active across several jurisdictions. Co-heads Christophe Ronse and Philippe de Jong bring deep IP and patent expertise, while Kirian Claeyé focuses on a wide array of regulatory issues related to clinical trials, market launch strategies and life cycle management.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team are responsive, provides translations of the law into practical advice, and is collaborative.’
- ‘The team provides quick advice and has deep knowledge of the applicable regulations.'
- ‘Kirian Claeyé is hands down the most knowledgeable lawyer in the Belgian life sciences industry.’
Key clients
- AbbVie
- Anicura
- Azelis
- Bayer Cropscience
- Bayer Pharma
- Beiersdorf
- Bolton Adhesives
- Equine America
- Euroseeds
- Ferring
- Gilead
- Hipra
Work highlights
Advised Syngenta, a member of the Biocontrol Coalition, on the legal advantages of adopting a distinct legal act for biocontrol products.
Represents and advises Bayer regarding the enforcement of orphan drug market exclusivity.
Advises Merck Sharp & Dohme in relation to the implementation of various new EU Directives and upcoming EU pharma reforms.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Christophe Ronse; Philippe de Jong; Kirian Claeyé
Other key lawyers
Bregt Raus